Adherence to antiretroviral therapy and its correlates among HIV-infected children at an HIV clinic in New Delhi

Annals of Tropical Paediatrics

Volumn 31, Issue 4, 2011, Pages 331-337

  Bhattacharya, M ^a   Dubey, A P ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EFAVIRENZ; NEVIRAPINE;

ARTICLE; CAREGIVER; CD4 LYMPHOCYTE COUNT; CHECKLIST; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INDIA; INDIAN; MAJOR CLINICAL STUDY; MALE; ORPHANED CHILD; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PRESCHOOL CHILD; RECALL; RELIABILITY; SCHOOL CHILD; SEX DIFFERENCE; STRUCTURED QUESTIONNAIRE; TREATMENT DURATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAREGIVERS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG MONITORING; FAMILY PRACTICE; FEMALE; HIV INFECTIONS; HUMANS; INDIA; INFANT; MALE; MEDICATION ADHERENCE; QUESTIONNAIRES;

EID: 80055030629     PISSN: 02724936     EISSN: 14653281     Source Type: Journal    
DOI: 10.1179/1465328111Y.0000000031     Document Type: Article

References (31)

1. Starr SE, Fletcher CV, Spector SA, et al. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. N Engl J Med 1999; 341:1874-81.
2. van Rossum AM, Geelen SP, Hartwig NG, et al. Results of 2 years of treatment with protease inhibitor-containing antiretroviral therapy in Dutch children infected with human immunodeficiency virus type 1. Clin Infect Dis 2002; 34:1008-16.
3. 3 Haynes RB. Compliance in Health Care (MD thesis). Baltimore, MA: Johns Hopkins University, 1979.
4. Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001; 345:1522-8.
5. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30.
6. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns 2002; 46:93-108.
7. Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics 2007; 119:e1371-83.
8. Patients Alive and on ART, August 2010. http://www.acoonline.org/upload/Care%20&%20Treatment/Patients%20alive%20and%20on%20ART/On%20ART%20March%202010.pdf
9. Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, van Dam J. Adherence to antiretroviral therapy and its determinants amongst HIV patients in India. Indian J Med Res 2008; 127:28-36.
10. Havens PL, Gibb DM. Increasing antiretroviral drug access for children with HIV infection. Pediatrics 2007; 119:838-45.
11. Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J 2008; 27:686-91.
12. Biadgilignl S, Deribew A, Amberbir A, de Deribe K. Adherence to highly active antiretroviral therapy and its correlates amongHIV infected pediatric patients in Ethiopia. BMC Pediatr 2008; 8:53.
13. Polisset J, Ametonou F, Arrive E, Aho A, Perez F. Correlates of adherence to antiretroviral therapy in HIV-infected children in Lome ́, Togo, West Africa. AIDS Behav 2009; 13:23-32.
14. Wrubel J, Moskowitz JT, Richards TA, Prakke H, Acree M, Folkman S. Pediatric adherence: perspectives of mothers of children with HIV. Soc Sci Med 2005; 61:2423-33.
15. Nyandiko WM, Ayaya S, Nabakwe E, et al. Outcome of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. J Acquir Immune Defic Syndr 2006; 43:418-25.
16. Vreeman RC, Wiehe SE, Ayaya SO, Musick BS, Nyandiko WM. Association of antiretroviral and clinic adherence with orphan status among HIVinfected children in western Kenya. J Acquir Immun Defic Syndr 2008; 49:163-70.
17. Giacomet V, Albano F, Starace F, de Franciscis A, Giaquinto C, Gattinara GC. Adherence to antiretroviral therapy and its determinants in children with human immunodeficiency virus infection: a multicentre, national study. Acta Pediatr 2003; 92:1398-1402.
18. Safreed-Harmon K, Siripong A, Kerr SJ, Gruskin S, Pancharoen C, Ananworanich J. Antiretroviral therapy adherence did not differ between Thai children with biological and those with nonbiological parents. Clin Infect Dis 2007; 45:669-70.
19. Cupsa A, Gheonea C, Bulucea D, Dinescu S. Factors with a negative influence on compliance to antiretroviral therapies. Ann NY Acad Sci 2000; 918:351-4.
20. Evans-Gilbert T, Pierre R, Steel-Duncan JC, et al. Antiretroviral drug therapy in HIV-infected Jamaican children. West Indian Med J 2004; 53:322-6.
21. Bikaako-Kajura W, Luyirika E, Purcell DW, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 2006; 10:S85-93.
22. Waugh S. Parental views on disclosure of diagnosis to their HIV-positive children. AIDS Care 2003; 15:169-76.
23. Blasini I, Chantry C, Cruz C, et al. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr 2004; 25:1-189.
24. Davies M, Boulle A, Fakir T, Nuttall J, Eley B. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr 2008; 8:34.
25. Williams PL, Storm D, Montepiedra G, Nichols S, Kammerer B, Sirois PA. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics 2006; 118:e1745-57.
26. Marhefka SL, Farley JJ, Rodrigue JR, Sandrik LL, Sleasman JW, Tepper VJ. Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP). AIDS Care 2004; 16:323-38.
27. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire. AIDS 2004; 18:1905-13.
28. Pontali E. Facilitating adherence to highly active antiretroviral therapy in children with HIV infection: what are the issues and what can be done? Paediatr Drugs 2005; 7:137-49.
29. Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J 2003; 22:56-62.
30. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004; 23:1035-41.
31. Martin S, Elliott-DeSorbo DK, Wolters PL, et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatr Infect Dis J 2007; 26:61-7.